Related Experiment Video
Updated: Feb 20, 2026

04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.6K
Screening for the patient at risk for postpartum depression
Obstetrics and Gynecology
|December 1, 1978
Summary
A new questionnaire identifies women at risk for postpartum emotional disorder (PED). Early detection allows for timely preventive measures to support maternal mental health.
Area of Science:
- Obstetrics and Gynecology
- Psychiatry
- Public Health
Background:
- Postpartum emotional disorder (PED) affects a significant number of women.
- Early identification of at-risk individuals is crucial for effective intervention.
- Existing screening methods may lack practicality or accuracy.
Purpose of the Study:
- To design and validate a simple, accurate, and practical device for detecting women at risk of developing postpartum emotional disorder (PED).
Main Methods:
- A 19-item "yes/no" questionnaire was administered to women attending a prenatal clinic.
- Patients were classified for the presence or absence of PED based on established criteria.
- Responses from patients with emotional disorders were compared to a control group.
Main Results:
- Thirteen percent of women developed postpartum emotional disorder.
- Six specific questionnaire items demonstrated predictive value for PED.
- Predictive factors included feeling unloved, undesired pregnancy, history of depression, single/separated status, marital problems, and unplanned pregnancy.
Conclusions:
- Integrating these six predictive items into routine prenatal history questionnaires can identify women at risk for PED.
- This approach facilitates the implementation of targeted preventive measures.
- The developed tool offers a practical method for early screening and intervention for postpartum emotional disorder.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
975
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
975
Depression: Overview
973
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
973

